Resistance of Onchocerca volvulus to ivermectin: A possibility to be considered;La resistance de Onchocerca volvulus a l'ivermectine: Une eventualite a considerer

Annales de l'Institut Pasteur/Actualites

Volumn 10, Issue 1, 1999, Pages 81-91

  Boussinesq, Michel ^a   Gardon, Jacques ^a  

^a Centre Pasteur du Cameroun   (Central African Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; IVERMECTIN;

DRUG MECHANISM; GENETIC RESISTANCE; HUMAN; MOLECULAR BIOLOGY; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; REVIEW;

ONCHOCERCA VOLVULUS;

EID: 0032740671     PISSN: 09244204     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-4204(99)80024-9     Document Type: Article

References (74)

1. Anderson R.M., May R.M., Infectious diseases of humans. Dynamics and Control, Oxford University Press, Oxford, 1991.
2. Arena J.P., Liu K.K., Paress P.S., Schaeffer J.M., Cully D.F., Expression of a glutamate-activated chloride current in Xenopus oocytes injected with Caenorhabditis elegans RNA: Evidence for modulation with ivermectin, Mol. Brain Res. 15 (1992) 339-348.
3. Arena J.P., Liu K.K., Paress P.S., Frazier E.G., Cully D.F., Mrozik H., Schaeffer J.M., The mechanism of action of avermectins in Caenorhabditis elegans: Correlation between activation of glutamatesensitive chloride current, membrane binding, and biological activity, J. Parasitol. 81 (1995) 286-294.
4. Avery L., Horvitz H.R., Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans, J. Exp. Zool. 253 (1990) 263-270.
5. Awadzi K., Opoku N.O., Addy E.T., Quartey B.T., The chemotherapy of onchocerciasis XIX: The clinical and laboratory tolerance of high dose ivermectin, Trop. Med. Parasitol. 46 (1995) 131-137.
6. Barnes E.H., Dobson R.J., Barger I.A., Worm control and anthelminthic resistance: Adventures with a model, Parasitol. Today 11 (1995) 56-63.
7. Barnes T.M., Hekimi S., The Caenorhabditis elegans avermectin resistance and anesthesic response gene unc-9 encodes a member of a protein family implicated in electrical coupling of excitable cells, J. Neurochem. 69 (1997) 2251-2260.
8. Bennett J.L., Pax R.A., Micromotility meter: An instrument designed to evaluate the action of drugs on motility of larval and adult nematodes, Parasitology 93 (1986) 341-346.
9. Blackhall W.J., Liu H.Y., Xu M., Prichard R.K., Beech R.N., Selection at a P-glycoprotein gene in ivermectin-and moxidectin-selected strains of Haemonchus contortus, Mol. Biochem. Parasitol. 95 (1998) 193-201.
10. Blackhall W.J., Pouliot J.F., Prichard R.K., Beech R.N., Haemonchus contortus: Selection at a glutamate-gated chloride channel gene in ivermectin-and moxidectin-selected strains, Exp. Parasitol. 90 (1998) 42-48.
11. Boussinesq M., Chippaux J.P., Ernould J.C., Quillévéré D., Prod'hon J., Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in Northern Cameroon, Am. J. Trop. Med. Hyg. 53 (1995) 63-67.
12. Boussinesq M., Gardon J., Gardon-Wendel N., Kamgno J., Ngoumou P., Chippaux J.P., Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis, Am. J. Trop. Med. Hyg. 58 (1998) 461-469.
13. Boussinesq M., Hougard J.M., La lutte contre l'onchocercose en Afrique : Aspects actuels, Méd. Trop. 58 (1998) 285-296.
14. Breton B., Diagne M., Wanji S., Bougnoux M.E., Chandre F., Maréchal P., Petit G., Vuong P.N., Bain O., Ivermectin and moxidectin in two filarial systems: Resistance of Monanema martini; inhibition of Litomosoides sigmondontis insemination, Parassitologia 39 (1997) 19-28.
15. Broeks A., Janssen H.W., Calafat J., Plasterk R.H., A P-glycoprotein protects Caenorhabditis elegans against natural toxins, EMBO J. 14 (1995) 1858-1866.
16. Brownlee D.J.A., Holden-Dye L., Walker R.J., Actions of the anthelmintic ivermectin on the pharyngeal muscle of the parasitic nematode, Ascaris suum, Parasitology 115 (1997) 553-561.
17. Chavasse D.C., Davies J.B., In vitro effects of ivermectin on Onchocerca volvulus microfilariae assessed by observation and by inoculation into Simulium damnosum sensu lato, Trans. R. Soc. Trop. Med. Hyg. 84 (1990) 707-708.
18. Comins H.N., The development of insecticide resistance in the presence of migration, J. Theor. Biol. 64 (1977) 177-197.
19. Comley J.C.W., Rees M.J., Turner C.H., Jenkins D.C., Colorimetric quantitation of filarial viability, Int. J. Parasitol. 19 (1989) 77-83.
20. Conder G.A., Campbell W.C., Chemotherapy of nematode infections of veterinary importance, with special reference to drug resistance, Adv. Parasitol. 35 (1995) 1-84.
21. Conder G.A., Thomson D.P., Johnson S.S., Demonstration of co-resistance of Haemonchus contortus to ivermectin and moxidectin, Vet. Rec. 132 (1993) 651-652.
22. Cully D.F., Vassilatis D.K., Liu K.K., Paress P.S., van der Ploeg L.H.T., Schaeffer J.M., Arena J.P., Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans, Nature 371 (1994) 707-711.
23. Cully D.F., Wilkinson H., Vassilatis D.K., Etter A., Arena J.P., Molecular biology and electrophysiology of glutamate-gated chloride channels of invertebrates, Parasitology 113 (1996) S191-S200.
24. De Clercq D., Sacko M., Behnke J., Gilbert F., Dorny P., Vercruysse J., Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali, Am. J. Trop. Med. Hyg. 57 (1997) 25-30.
25. Dent J.A., Davis M.W., Avery L., avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans, EMBO J 16 (1997) 5867-5879.
26. Didier A., Loor F., The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor, Anti-Cancer Drugs 7 (1996) 745-751.
27. Dobson R.J., LeJambre L., Gill J.H., Management of anthelminthic resistance: Inheritance of resistance and selection with persistent drugs, Int. J. Parasitol. 26 (1996) 993-1000.
28. Echevarria F.A., Gennari S.M., Tait A., Isoenzyme analysis of Haemonchus contortus resistant or susceptible to ivermectin, Vet. Parasitol. 44 (1992) 87-95.
29. Foote J.A., Cowman A.F., The mode of action and mechanism of resistance to antimalarial drugs, Acta Trop. 56 (1994) 157-171.
30. Gardon J., Gardon-Wendel N., Demanga-Ngangue, Kamgno J., Chippaux J.P., Boussinesq M., Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection, Lancet 350 (1997) 18-22.
31. Geary T.G., Sims S.M., Thomas E.M., Vanover L., Davis J.P., Winterrowd C.A., Klein R.D., Ho N.F.H., Thomson D.P., Haemonchus contortus: Ivermectininduced paralysis of the pharynx, Exp. Parasitol. 77 (1993) 88-96.
32. Geerts S., Coles G.C., Gryseels B., Anthelmintic resistance in human helminths: Learning from the problems with worm control in livestock, Parasitol. Today 13 (1997) 149-151.
33. Gill J.H., Kerr C.A., Shoop W.L., Lacey E., Evidence of multiple mechanisms of avermectin resistance in Haemonchus contortus - comparison of selection protocols, Int. J. Parasitol. 28 (1998) 783-789.
34. Gill J.H., Lacey E., In vitro activity of paraherquamide against the free-living stages of Haemonchus contortus, Trichostrongylus colubriformis and Ostertagia circumcincta, Int. J. Parasitol. 23 (1993) 375-381.
35. Gill J.H., Lacey E., Avermectin/milbemycin resistance in trichostrongyloid nematodes, Int. J. Parasitol. 28 (1998) 863-877.
36. Gill J.H., Redwin J.M., Van Wyk J.A., Lacey E., Detection of resistance to ivermectin in Haemonchus contortus, Int. J. Parasitol. 21 (1991) 771-776.
37. Gill J.H., Redwin J.M., Van Wyk J.A., Lacey E., Avermectin inhibition of larval development in Haemonchus contortus -effects of ivermectin resistance, Int. J. Parasitol. 25 (1995) 463-470.
38. Grant W.N., Genetic variation in parasitic nematodes and its implications, Int. J. Parasitol. 24 (1994) 821-830.
39. Kotze A.C., Effects of macrocyclic lactones on ingestion in susceptible and resistant Haemonchus contortus larvae, J. Parasitol. 84 (1998) 631-635.
40. Kwa M.S.G., Okoli M.N., Schulz-Key H., Okonkwo P.O., Roos M.H., Use of P-glycoprotein gene probes to investigate anthelmintic resistance in Haemonchus contortus and comparison with Onchocerca volvulus, Int. J. Parasitol. 28 (1998) 1235-1240.
41. Laughton D.L., Lunt G.G., Wolstenholme A.J., Reporter gene constructs suggest that the Caenorhabditis elegans avermectin receptor β-subunit is expressed solely in the pharynx, J. Exp. Biol. 200 (1997) 1509-1514.
42. Laughton D.L., Lunt G.G., Wolstenholme A.J., Alternative splicing of a Caenorhabditis elegans gene produces two novel inhibitory amino acid receptor subunits with identical ligand binding domains but different ion channels, Gene 201 (1997) 119-125.
43. Laughton D.L., Wheeler S.V., Lunt G.G., Wolstenholme A.J., The β-subunit of Caenorhabditis elegans avermectin receptor responds to glycine and is encoded by chromosome 1, J. Neurochem. 64 (1995) 2354-2357.
44. LeJambre L.F., Ivermectin-resistant Haemonckus contortus in Australia, Aust. Vet. J. 70 (1993) 357.
45. LeJambre L.F., Gill J.H., Lenane I.J., Lacey E., Characterisation of an avermectin resistant isolate of Australian Haemonchus contortus, Int. J. Parasitol. 25 (1995) 691-698.
46. Lincke C.R., The I., van Groenigen M., Borst P., The P-glycoprotein family of Caenorhabditis elegans. Cloning and characterization of genomic and complementary DNA sequences, J. Mol. Biol. 228 (1992) 701-711.
47. Martin R.J., An electrophysiological preparation of Ascaris suum pharyngeal muscle reveals a glutamate-gated chloride channel sensitive to the avermectin analogue, milbemycin D, Parasitology 112 (1996) 247-252.
48. Martin R.J., Pennington A.J., A patchclamp study of effects of dihydroavermectin on Ascaris muscle, Br. J. Pharmacol. 98 (1989) 747-756.
49. Molyneux D.H., Davies J.B., Onchocerciasis control: Moving towards the millenium, Parasitol. Today 13 (1997) 418-424.
50. Mukherjee M., Misra S., Chatterjee R.K., Development of in vitro screening system for assessment of antifilarial activity of compounds, Acta Trop. 70 (1998) 251-255.
51. Plaisier A.P., van Oortmarssen G.J., Habbema J.D.F., Remme J., Alley E.S., ONCHOSIM: A model and computer simulation program for the transmission and control of onchocerciasis, Comp. Meth. Prog. Biomed. 31 (1990) 43-56.
52. Pouliot J.F., L'Heureux F., Liu Z., Prichard R.K., Georges E., Reversal of P-glycoprotein-associated multidrug resistance by ivermectin, Biochem. Pharmacol. 10 (1997) 17-25.
53. Rand J.B., Johnson C.D., Genetic pharmacology: Interactions between drugs and gene products in Caenorhabditis elegans, in : Epstein G.F., Shakes D.C., (éd.), Methods in cell biology, vol. 48, Caenorhabditis elegans: Modern Biological Analysis of an Organism, Academic Press, San Diego, CA, 1995, pp. 187-204.
54. Remme J.H.F., The African programme for Onchocerciasis control: Preparing to launch, Parasitol. Today 11 (1995) 403-406.
55. Richards J.C., Behnke J.M., Duce I.R., In vitro studies on the relative sensitivity to ivermectin of Necator americanus and Ancylostoma ceylanicum, Int. J. Parasitol. 25 (1995) 1185-1191.
56. Rohrer S.P., Birzin E.T., Eary C.H., Schaeffer J.M., Shoop W.L., Ivermectin binding sites in sensitive and resistant Haemonchus contortus, J. Parasitol. 80 (1994) 493-497.
57. Roos M.H., Kwa M.S.G., Grant W.N., New genetic and practical implications of selection for anthelmintic resistance in parasitic nematodes, Parasitol. Today 11 (1995) 148-150.
58. Sangster N., Pharmacology of anthelmintic resistance, Parasitology 113 (1996) S201-S216.
59. Schinkel A.H., Smit J.J., Van Tellingen O., Beijnen J.H., Wagenaar E., Van Deemter L., Mol C.A., Valk M.A., Robanus-Maandag E.C., Te Riele H.P., Borst P., Disruption of the mouse mar1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell 77 (1994) 491-502.
60. Shoop W.L., Ivermectin resistance, Parasitol. Today 9 (1993) 154-159.
61. Shoop W.L., Haines H.W., Michael B.F., Eary C.H., Mutual resistance to avermectins and milbemycins: Oral activity of ivermectin and moxidectin against ivermectin-resistant and susceptible nematodes, Vet. Rec. 133 (1993) 445-447.
62. Shoop W.L., Mrozik H., Fisher M.H., Structure and activity of avermectins and milbemycins in animal health, Vet. Parasitol. 59 (1995) 139-156.
63. Strote G., Bokhof A., Comley J.C.W., Viability of Onchocerca volvulus in vitro, Parasitology 107 (1993) 175-182.
64. Strote G., Bonow I., Attah S., The ultrastructure of the anterior end of male Onchocerca volvulus: Papillae, amphids, nerve ring and first indication of an excretory system in the adult filarial worm, Parasitology 113 (1996) 71-85.
65. Sutherland I.A., Lee D.L., Lewis D., Detection of benzimidazole resistance in trichostrongylid nematodes, Parasitol. Today 4 (1988) 22-24.
66. Tagboto S.K., Townson S., Onchocerca volvulus and O. lienalis: The microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo, Ann. Trop. Med. Parasitol. 90 (1996) 497-505.
67. Tagboto S.K., Townson S., Titanji V.P.K., Awadzi K., Castro J., Zea-Flores G., Comparison of the sensitivity of different geographical isolates of Onchocerca volvulus microfilariae to ivermectin: Effects of exposure to drug on development in the blackfly Simulium ornatum, Trans. R. Soc. Trop. Med. Hyg. 88 (1994) 237-241.
68. Thompson D.P., Klein R.D., Geary T.G., Prospects for rational approaches to
69. Townson S., Tagboto S.K., The effects of ivermectin on the viability of Onchocerca lienalis microfilariae in vitro and on their subsequent development in the blackfly vector, Simulium ornatum, Trop. Med. Paraitol. 42 (1991) 31-37.
70. Townson S., Tagboto S.K., Castro J., Lujan A., Awadzi K., Titanji V.P.K., Comparison of the sensitivity of different geographical races of Onchocerca volvulus microfilariae to ivermectin: Studies in vitro, Trans. R. Soc. Trop. Med. Hyg. 88 (1994) 101-106.
71. Trees A.J., Wood V.L., Bronsvoort M., Renz A., Tanya V.N., Animal models - Onchocerca ochengi and the development of chemtherapeutic and chemoprophylactic agents for onchocerciasis, Ann. Trop. Med. Parasitol. 92 (1998) S175-S179.
72. Vassilatis D.K., Arena J.P., Plasterk R.H.A., Wilkinson H.A., Schaeffer J.M., Cully D.F., Van der Ploeg L.H.T., Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel en Caenorhabditis elegans. Isolation and characterization, J. Biol. Chem. 272 (1997) 33167-33174.
73. Wood R.J., Bishop J.A., Insecticide resistance: Populations and evolution, in : Bishop J.A., Cook L.M., (éd.), Genetic Consequences of Man Made Change, Academic Press, New York, 1981, pp. 97-127.
74. Xu M., Molento M., Blackhall W., Ribeiro P., Beech R., Prichard R., Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog, Mol. Biochem. Parasitol. 91 (1998) 327-335.